The study is an experimental pre-post-test design involving 12 patients with severe ED non-responsive to sildenafil. Safety parameters included pain, hematoma, local bleeding, and infection, while efficacy was measured using the IIEF-5 questionnaire, EHS, and morning erection.
Age range
40 Years – 65 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Visual Analog Scale
Timeframe: one day and one month
Hematomes
Timeframe: one day and one month
Bleeding
Timeframe: one day and one month
Erection Hardness Score
Timeframe: One month
IIEF-5
Timeframe: One month
Restrictive Index
Timeframe: one month
PSV
Timeframe: one month
SPL
Timeframe: one month
FPL
Timeframe: one month
Penile Circumference
Timeframe: one month